The intelligence behind better health AI decisions.

Understand health AI
from evidence
to adoption.

Independent news coverage, company intelligence, and public evidence—connected so you can follow the stories, organizations, and research shaping health AI.
02 · Company Intelligence

See who is building—and the evidence around them.

Company dossiers organize what an organization says, what the public record shows, and where HAIC news coverage adds context.

Browse the company directory →

Pathology & Laboratory Diagnostics

Recent coverage · October 17, 2026

Aignostics

Aignostics develops AI-powered pathology solutions for precision medicine, specializing in tumor microenvironment analysis from H&E-stained whole slide images. The company serves life sciences companies and academic researchers with foundation models and custom analytics services.

View company dossier →

Remote Patient Monitoring & Wearables

Recent coverage · October 15, 2026

Fitbit

Fitbit, now part of Google, develops activity trackers, smartwatches, and health monitoring wearables that help users track fitness, sleep, and overall wellness. The company offers devices ranging from screenless trackers to advanced smartwatches integrated with Google's AI-powered health coaching.

View company dossier →

Generative AI & Healthcare Infrastructure

Recent coverage · October 14, 2026

OpenEvidence

OpenEvidence is the most widely used medical AI platform among U.S. physicians, trusted by hundreds of thousands of verified clinicians for point-of-care clinical decisions. The platform delivers evidence-based answers sourced from partnerships with NEJM, JAMA, NCCN, Cochrane, Wiley, and leading medical societies.

View company dossier →

Mental Health & Digital Therapeutics

Recent coverage · October 13, 2026

Click Therapeutics

Click Therapeutics develops FDA-regulated prescription digital therapeutics (PDTs) and software-enhanced drugs that combine neuroscience with software to treat diseases with neurological or behavioral components. Their platform delivers evidence-based mobile treatments for conditions including depression, migraine, schizophrenia, and diabetes.

View company dossier →
Weekly Digest

Make sense of health AI each week.

Get a concise Friday briefing on the health-AI news, company developments, and research signals worth your attention.